Mandeep Singh is an Ophthalmology physician affiliated with Johns Hopkins University. OpenAlex indexes 150 publications with 3,743 citations (h-index 30); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Suite Maumenee 723
Baltimore, MD 212870005
Telephone
410-502-2789Registry record last updated 10 May 2016.
Clinical trials
- Gyrate Atrophy Ocular and Systemic Study
Sponsor: Jaeb Center for Health Research
- Clopidogrel Monotherapy in Patients With High Bleeding Risk
Sponsor: Mayo Clinic
- Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults
Sponsor: Mayo Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Pharmaceuticals, IncProgram year20251 payment
- Janssen Pharmaceuticals, IncProgram year202419 payments$28,780openpaymentsdata.cms.gov ↗
- Sumitomo Pharma America, Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
96.8%Vascular Endothelial Growth Factor Inhibitor96.8%Aflibercept100%Part B, office-administered≥51 patientsSensory organs
3.2%Carbonic Anhydrase Inhibitor3.2%Dorzolamide Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2021–2025 per NIH RePORTER. The latest:
- Developing photoreceptor repair for macular degeneration therapy.
Johns Hopkins University
FY2025$347,472R01EY033103 - Developing photoreceptor repair for macular degeneration therapy.
Johns Hopkins University
FY2024$408,791R01EY033103 - Developing photoreceptor repair for macular degeneration therapy.
Johns Hopkins University
FY2023$408,791R01EY033103
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Laheru, MD
Johns Hopkins University
Demosthenes G. Katritsis
Johns Hopkins University
Tanguy Seiwert, MD
Johns Hopkins University
Evan Lipson, MD
Johns Hopkins University
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”